Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Lepage

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1997
Pharmacokinetics and metabolism of the novel anticonvulsant agent N-(2,6-dimethylphenyl)-5-methyl-3-isoxazolecarboxamide (D2624) in rats and humansS W Martin, F E Bishop, B M Kerr, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 12, 2024
A W1282X cystic fibrosis mouse allows the study of pharmacological and gene-editing therapeutics to restore CFTR functionMargaret Michicich, Zachary Traylor, Caitlan McCoy, et al.
Clinical Pharmacology and Therapeutics|December 9, 1997
Influence of stiripentol on cytochrome P450-mediated metabolic pathways in humans: in vitro and in vivo comparison and calculation of in vivo inhibition constantsA Tran, E Rey, G Pons, et al.
Nature|July 2, 2020
Suppression of proteolipid protein rescues Pelizaeus-Merzbacher diseaseMatthew S Elitt, Lilianne Barbar, H Elizabeth Shick, et al.
Science (New York, N.Y.)|June 13, 2024
In vivo editing of lung stem cells for durable gene correction in miceYehui Sun, Sumanta Chatterjee, Xizhen Lian, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1997
Pharmacokinetics and metabolism of the novel anticonvulsant agent N-(2,6-dimethylphenyl)-5-methyl-3-isoxazolecarboxamide (D2624) in rats and humansS W Martin, F E Bishop, B M Kerr, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 12, 2024
A W1282X cystic fibrosis mouse allows the study of pharmacological and gene-editing therapeutics to restore CFTR functionMargaret Michicich, Zachary Traylor, Caitlan McCoy, et al.
Clinical Pharmacology and Therapeutics|December 9, 1997
Influence of stiripentol on cytochrome P450-mediated metabolic pathways in humans: in vitro and in vivo comparison and calculation of in vivo inhibition constantsA Tran, E Rey, G Pons, et al.
Nature|July 2, 2020
Suppression of proteolipid protein rescues Pelizaeus-Merzbacher diseaseMatthew S Elitt, Lilianne Barbar, H Elizabeth Shick, et al.
Science (New York, N.Y.)|June 13, 2024
In vivo editing of lung stem cells for durable gene correction in miceYehui Sun, Sumanta Chatterjee, Xizhen Lian, et al.
Pageof 6